China SXT Pharmaceuticals (SXTC) Payables: 2018-2025
- China SXT Pharmaceuticals' Payables rose 17.93% to $976,367 in Q3 2025 from the same period last year, while for Sep 2025 it was $11.5 million, marking a year-over-year increase of 161.65%. This contributed to the annual value of $8.0 million for FY2025, which is 349.63% up from last year.
- Latest data reveals that China SXT Pharmaceuticals reported Payables of $976,367 as of Q3 2025, which was down 87.75% from $8.0 million recorded in Q1 2025.
- In the past 5 years, China SXT Pharmaceuticals' Payables registered a high of $8.0 million during Q1 2025, and its lowest value of $24,042 during Q3 2021.
- For the 3-year period, China SXT Pharmaceuticals' Payables averaged around $2.2 million, with its median value being $1.3 million (2023).
- Per our database at Business Quant, China SXT Pharmaceuticals' Payables crashed by 56.22% in 2023 and then surged by 349.63% in 2025.
- China SXT Pharmaceuticals' Payables (Quarterly) stood at $24,042 in 2021, then increased by 14.44% to $3.5 million in 2022, then tumbled by 56.22% to $267,270 in 2023, then surged by 209.77% to $827,918 in 2024, then increased by 17.93% to $976,367 in 2025.
- Its Payables was $976,367 in Q3 2025, compared to $8.0 million in Q1 2025 and $827,918 in Q3 2024.
